23.11.2014 Views

HEART FAILURE REFERRAL GUIDELINE –TARANAKI DHB & PHO's

HEART FAILURE REFERRAL GUIDELINE –TARANAKI DHB & PHO's

HEART FAILURE REFERRAL GUIDELINE –TARANAKI DHB & PHO's

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>HEART</strong> <strong>FAILURE</strong> <strong>REFERRAL</strong> <strong>GUIDELINE</strong> –TARANAKI <strong>DHB</strong> & PHO’s<br />

March 2012<br />

PROBLEM ACTION IMPLEMENTATION LIKELY<br />

PRIORITY<br />

<strong>HEART</strong> <strong>FAILURE</strong><br />

Dyspnoea on<br />

exertion,<br />

orthopnoea,<br />

unexplained<br />

confusion or fatigue<br />

+/- oedema, nausea,<br />

abdominal pain<br />

Heart failure suspected<br />

ECG abnormal<br />

and/or<br />

BNP elevated or<br />

increasing over<br />

time;<br />

+ Clinical findings<br />

Clinical history<br />

Consider age, onset of symptoms,<br />

previous heart disease, family<br />

history, myocardial infarction,<br />

angina, hypertension, valvular<br />

heart disease, rheumatic fever,<br />

palpitations, alcohol & tobacco use,<br />

medications.<br />

Rule-out recent infarct, PE, etc<br />

Echocardiography<br />

(to assess LV function)<br />

(NB: If cause of HF clear, echo may<br />

not be necessary –or be given lower<br />

priority)<br />

Chest Xray<br />

12 lead ECG and<br />

Natriuretic peptides (BNP)<br />

Other recommended tests:<br />

FBC, U/E/creatinine, TFT, LFT,<br />

glucose, lipids, urinalysis,<br />

peak flow or spirometry<br />

Refer cardiology dept (or private)<br />

If echocardiography delayed<br />

commence / continue treatment on<br />

an empirical basis.<br />

Priority 1-3<br />

Heart failure<br />

confirmed<br />

Abnormal echo<br />

No abnormality<br />

detected<br />

Normal echo<br />

Assess HF severity, aetiology,<br />

precipitating and exacerbating<br />

factors Correctable courses must be<br />

identified/treated.<br />

Heart failure unlikely, but if<br />

diagnostic doubt persists consider<br />

diastolic dysfunction<br />

Review for other causes of<br />

symptoms<br />

Non pharmacological management<br />

(see notes attached)<br />

Pharmacological management (see<br />

treatment algorithm)<br />

Consider specialist cardiology<br />

referral (see recommendations below)<br />

Consider referral for specialist<br />

assessment (private or public)<br />

Priority 1-2<br />

Priority 2-3<br />

Recommendations for specialist referral:<br />

For patients with heart failure specialist advice is recommended in the following situations:<br />

Heart failure due to valve disease, diastolic dysfunction or any other cause except LV<br />

systolic dysfunction<br />

One or more co-morbidities<br />

Angina, atrial fibrillation or other symptomatic arrhythmia<br />

Women who are planning a pregnancy or who are pregnant<br />

Severe heart failure<br />

Heart failure that does not respond to treatment according to guideline recommendations<br />

Heart failure that cannot be managed effectively in the home setting


Treatment algorithm of symptomatic heart failure<br />

General Practitioner<br />

New Diagnosis<br />

Add Diuretic<br />

Diuretic therapy is<br />

likely to be<br />

required to control<br />

congestive<br />

symptoms and<br />

fluid retention.<br />

Start ACE<br />

inhibitor and<br />

titrate upwards<br />

Or if ACE inhibitor not<br />

tolerated (eg due to<br />

severe cough) Consider<br />

angiotensin-II receptor<br />

antagonist<br />

Specialist Input<br />

Add Digoxin<br />

If a patient in sinus<br />

rhythm remains<br />

symptomatic<br />

despite therapy<br />

with a diuretic<br />

ACE Inhibitor (or<br />

angiotensin-II<br />

receptor<br />

antagonist) and<br />

beta-blocker.<br />

OR if a patient is<br />

in atrial fibrillation<br />

then use as first<br />

line therapy<br />

Add beta-blocker<br />

and titrate upwards<br />

(if LV dysfunction)<br />

Add spironolactone<br />

If patient remains<br />

moderately to severely<br />

symptomatic despite<br />

optimal drug therapy<br />

listed above<br />

Monitor 6-monthly<br />

-clinical assessment<br />

-medication review<br />

-u/e/creatinine<br />

Seek specialist advice<br />

for further options<br />

Specialist<br />

Non pharmacological management<br />

General counselling (compliance issues)<br />

Record weight daily (for diuretic titration)<br />

Smoking cessation programmes where necessary<br />

Exercise programmes<br />

Diet, particularly low-salt<br />

Limit alcohol intake<br />

References<br />

Management of Chronic Heart Failure. NZ Guideline Group (NZGG) 2001<br />

Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. National Institute for<br />

Clinical Excellence (NICE) UK ) October 2003<br />

Assessment and management of cardiovascular risk. NZ Guidelines Group, (NZGG), December 2003<br />

Cardiac rehabilitation, New Zealand Guidelines Group (NZGG) August 2002

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!